Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cocrystal Pharma Inc.

    NASDAQ: COCP · Real-Time Price · USD
    1.54
    0.00 (0.00%)
    At close: Jun 13, 2025, 3:59 PM
    1.60
    3.90%
    After-hours: Jun 13, 2025, 06:26 PM EDT

    Cocrystal Pharma Statistics

    Share Statistics

    Cocrystal Pharma has 10.17M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 10.17M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 6.99%

    Shares Floating

    n/a
    		 6.95M

    Failed to Deliver (FTD) Shares

    n/a
    		 22

    FTD / Avg. Volume

    n/a
    		 0.11%

    Short Selling Information

    The latest short interest is 13.72K, so 0.13% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 13.72K

    Short % of Shares Out

    n/a
    		 0.13%

    Short % of Float

    n/a
    		 0.18%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.17 and the forward PE ratio is -1.13. Cocrystal Pharma's PEG ratio is 0.

    PE Ratio

    n/a
    		 -1.17

    Forward PE

    n/a
    		 -1.13

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.16

    P/FCF Ratio

    n/a
    		 -1.25

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cocrystal Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.77, with a Debt / Equity ratio of 0.19.

    Current Ratio

    n/a
    		 4.77

    Quick Ratio

    n/a
    		 4.77

    Debt / Equity

    n/a
    		 0.19

    Debt / EBITDA

    n/a
    		 -0.1

    Debt / FCF

    n/a
    		 -0.11

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,591,272.73

    Employee Count

    n/a
    		 11

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -35.56% in the last 52 weeks. The beta is 2.12, so Cocrystal Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.12

    52-Week Price Change

    n/a
    		 -35.56%

    50-Day Moving Average

    n/a
    		 1.48

    200-Day Moving Average

    n/a
    		 1.79

    Relative Strength Index (RSI)

    n/a
    		 48.4

    Average Volume (20 Days)

    n/a
    		 19,431

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -17.88M

    Net Income

    n/a
    		 -17.5M

    EBITDA

    n/a
    		 -17.43M

    EBIT

    n/a
    		 -17.88M

    Earnings Per Share (EPS)

    n/a
    		 -1.72
    Full Income Statement

    Balance Sheet

    The company has 9.86M in cash and 1.81M in debt, giving a net cash position of 8.05M.

    Cash & Cash Equivalents

    n/a
    		 9.86M

    Total Debt

    n/a
    		 1.81M

    Net Cash

    n/a
    		 8.05M

    Retained Earnings

    n/a
    		 -333.42M

    Total Assets

    n/a
    		 10.66M

    Working Capital

    n/a
    		 6.89M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -16.48M and capital expenditures -8K, giving a free cash flow of -16.49M.

    Operating Cash Flow

    n/a
    		 -16.48M

    Capital Expenditures

    n/a
    		 -8K

    Free Cash Flow

    n/a
    		 -16.49M

    FCF Per Share

    n/a
    		 -1.62
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    COCP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for COCP is $7, which is 354.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 354.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 11, 2022. It was a backward split with a ratio of 1:12.

    Last Split Date

    n/a
    		 Oct 11, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:12

    Scores

    Altman Z-Score

    n/a
    		 -42.16

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist